We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Janssen Follows Gilead in Filing Federal Lawsuit to Stop Counterfeit Versions of Its HIV Drugs
Janssen Follows Gilead in Filing Federal Lawsuit to Stop Counterfeit Versions of Its HIV Drugs
Johnson & Johnson (J&J) subsidiary Janssen has become the second big pharma company to go after drug distributors to stop the sale of counterfeit versions of its HIV drugs.